Which drug is used to treat hyperuricemia by inhibiting xanthine oxidase?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

Which drug is used to treat hyperuricemia by inhibiting xanthine oxidase?

Explanation:
Blocking xanthine oxidase, the enzyme that converts purines into uric acid, lowers uric acid production. Allopurinol fits this role because it’s a purine analog that, after metabolism to oxypurinol, potently inhibits xanthine oxidase. This reduces the formation of uric acid, helping to lower serum urate levels and prevent gout flares and urate crystal deposition. It’s a standard, long-established therapy for chronic gout and for preventing tumor lysis–related hyperuricemia. Other options work differently: some increase uric acid excretion, one degrades existing uric acid, and another XO inhibitor exists as an alternative, but allopurinol is the classic drug used to reduce uric acid production by inhibiting xanthine oxidase.

Blocking xanthine oxidase, the enzyme that converts purines into uric acid, lowers uric acid production. Allopurinol fits this role because it’s a purine analog that, after metabolism to oxypurinol, potently inhibits xanthine oxidase. This reduces the formation of uric acid, helping to lower serum urate levels and prevent gout flares and urate crystal deposition. It’s a standard, long-established therapy for chronic gout and for preventing tumor lysis–related hyperuricemia. Other options work differently: some increase uric acid excretion, one degrades existing uric acid, and another XO inhibitor exists as an alternative, but allopurinol is the classic drug used to reduce uric acid production by inhibiting xanthine oxidase.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy